Primary mutations selected in vitro with raltegravir confer large fold changes in susceptibility to first-generation integrase inhibitors, but minor fold changes to inhibitors with second-generation resistance profiles (Q34112243)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q56811048)
(Q47698773)
(P304) 338-346
(P407) (Q1860)
(P433) 2
(P478) 402
(P577) Saturday, April 24, 2010
(P921) (Q421552)
(P1104) 9
(P1433) (Q7934867)
(P1476) "Primary mutations selected in vitro with raltegravir confer large fold changes in susceptibility to first-generation integrase inhibitors, but minor fold changes to inhibitors with second-generation resistance profiles" (language: en)
(P2093) Olivia Goethals
Marcia Van Ginderen
Peggy Geluykens
Veerle Smits
Kurt Hertogs
Reginald Clayton
(P2860) (Q37039007)
(Q40868886)
(Q61952148)
(Q38425605)
(Q34787580)
(Q59448085)
(Q46466415)
(Q80176025)
(Q39897913)
(Q67802014)
(Q30175416)
(Q45541112)
(Q36538764)
(Q36949688)
(Q45405108)
(Q37388364)
(Q28369295)
(Q38898868)
(Q56156635)
(Q39961703)
(Q33884269)
(Q36538644)
(Q79390358)
(Q33896796)
(Q43698752)
(Q29547281)
(Q34397376)
(Q46445750)
(Q34223088)
(Q36452096)
(Q40310128)
(Q28288290)
(Q41170596)
(Q35867086)
(Q30341397)
(Q40038402)
(Q40062287)
other details